CRISPR Technology: Global Markets

Home > Market Research Reports > Pharmaceutical

Gene Therapeutics & RNAi Genome-based Drug Discovery

	Market Research Report CRISPR Technology: Global Markets
Published by	BCC Research			Product code	936417
Published	May 8, 2020	Content info	83 Pages Delivery time: 1-2 business days
Price	PDF (Single User License) USD 5500 PDF (2-5 Users) USD 6600 PDF (Site License) USD 7920 PDF (Enterprise License) USD 9504

Description

Highlights:

The global market for CRISPR technology should grow from $75.0 billion in 2018 to $218.9 billion by 2023, at a compound annual growth rate (CAGR) of 23.9% for the period of 2018-2023.

Biotechnology companies market should grow from $24.9 billion in 2018 to $73.3 billion by 2023 at a CAGR of 24.1% through 2023.

Pharmaceutical companies market should grow from $17.0 billion in 2018 to $52.8 billion by 2023 at a CAGR of 25.4% through 2023.

Report Scope:

The scope of this report is broad, covering the applications of CRISPR in medicine, drug therapy and agriculture. The market for CRISPR technology is broken down by application and end user. Revenue forecasts from 2018-2023 are given for each end user category and application with estimated value derived from the revenue of the companies' total revenues.

This report also includes a discussion of the major players across each regional market for CRISPR technology with respect to prominent strategic initiatives. Further, it explains the main drivers and regional dynamics of the global market and current trends within the industry.

Report Includes:

45 data tables and 35 additional tables

An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms

Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023

Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast

Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases

Information on congenital anomalies, its prevalence, causes and its relation to mortality rate

Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells

Insights into regulatory framework and investment analysis

Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific

Table of Contents

Product Code: HLC258A

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

CRISPR: Genetic Editing
Pros of Genetic Editing
CRISPR Development Phases
Discovery of CRISPR
Discovery of Cas9 and PAM
Hypothesis: Adaptive Immunity
Adaptive Immunity
Spacer Sequences: gRNAs
CRISPR Acts on DNA Targets
Cas9 Cleaves Target DNA
tracrRNA for Cas9 Systems
CRISPR Systems in Other Species
Cas9-Mediated Cleavage
CRISPR-Cas9: Genome Editing
Market Potential
Regulatory Framework
U.S. Regulation and Oversight
NIH Guidelines
U.S. FDA
Ethical Considerations
Regulatory Issues
Regulations of Human Germline Edits
Global Regulations
Porter's Five Forces Analysis
Patent Analysis
Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
Industry Drivers
CRISPR versus Disease
Government Funding
CRISPR in Other Fields
Industry Restraints
Alternative Technologies
Industry Challenges
Patent Issues

Chapter 4 Industry Structure

Commercial Therapeutics
Correcting Genetic Errors
Microbes
Healthier Food

Chapter 5 Competitive Landscape

Cellectis
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Sangamo Therapeutics

Chapter 6 Global Market for CRISPR Technology by End User

Academic Institutes
Research and Development Institutes
Pharmaceutical Companies
Biotechnology Companies

Chapter 7 Global Market for CRISPR Technology by Application

Cell Line Engineering
CRISPR Plasmid
Genetic Engineering
GRNA Databases/Gene Libraries
Human Stem Cells

Chapter 8 Global Market for CRISPR Technology by Region

North America
U.S.
Europe
UK
Asia-Pacific
China
India
Rest of the World

Chapter 9 Company Profiles

CARIBOU BIOSCIENCES
CRISPR THERAPEUTICS
EDITAS MEDICINE
GENSCRIPT
HORIZON DISCOVERY PLC
INTEGRATED DNA TECHNOLOGIES
INTELLIA THERAPEUTICS INC.
LONZA GROUP LTD.
NEW ENGLAND BIOLABS INC.
ORIGENE TECHNOLOGIES
PRECISION BIOSCIENCES
SANGAMO THERAPEUTICS INC.
THERMO FISHER SCIENTIFIC
TRANSPOSAGENBIO BIOPHRAMACEUTICALS (HERA BIOLABS)

List of Tables

Summary Table : Global Market for CRISPR Technology, by End User, Through 2023
Table 1 : Selected Monogenic Disease Details
Table 2 : CRISPR Application
Table 3 : Selected CAR-T/Gene-Editing Collaborations
Table 4 : CRISPR Technology: Selected Companies
Table 5 : CRISPR Technology: Selected Mergers and Acquisitions
Table 6 : CRISPR Technology: Selected Joint Ventures
Table 7 : CRISPR Technology: Recent Developments
Table 8 : CRISPR Technology: Competitive Scenario
Table 9 : Global Market for CRISPR Technology Used by Academic Institutes, Through 2023
Table 10 : Global Market for CRISPR Technology Used by Academic Institutes, by Region, Through 2023
Table 11 : Global Market for CRISPR Technology Used by R&D Institutes, Through 2023
Table 12 : Global Market for CRISPR Technology Used by R&D Institutes, by Region, Through 2023
Table 13 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, Through 2023
Table 14 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, by Region, Through 2023
Table 15 : Global Market for CRISPR Technology Used by Biotechnology Companies, Through 2023
Table 16 : Global Market for CRISPR Technology Used by Biotechnology Companies, by Region, Through 2023
Table 17 : Global Market for CRISPR Technology, by Application, Through 2023
Table 18 : Global Market for CRISPR Technology in Cell Line Engineering Applications, Through 2023
Table 19 : Global Market for CRISPR Technology in Cell Line Engineering Applications, by Region, Through 2023
Table 20 : Global Market for CRISPR Technology in Plasmid Applications, Through 2023
Table 21 : Global Market for CRISPR Technology in Plasmid Applications, by Region, Through 2023
Table 22 : Global Market for CRISPR Technology in Genetic Engineering Applications, Through 2023
Table 23 : Global Market for CRISPR Technology in Genetic Engineering Applications, by Region, Through 2023
Table 24 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, Through 2023
Table 25 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, by Region, Through 2023
Table 26 : Global Market for CRISPR Technology in Human Stem Cell Applications, Through 2023
Table 27 : Global Market for CRISPR Technology in Human Stem Cell Applications, by Region, Through 2023
Table 28 : Global Market for CRISPR Technology, by Region, Through 2023
Table 29 : North American Market for CRISPR Technology, Through 2023
Table 30 : North American Market for CRISPR Technology, by End User, Through 2023
Table 31 : North American Market for CRISPR Technology, by Application, Through 2023
Table 32 : U.S. Market for CRISPR Technology, Through 2023
Table 33 : U.S. Market for CRISPR Technology, by End User, Through 2023
Table 34 : U.S. Market for CRISPR Technology, by Application, Through 2023
Table 35 : European Market for CRISPR Technology, Through 2023
Table 36 : European Market for CRISPR Technology, by End User, Through 2023
Table 37 : European Market for CRISPR Technology, by Application, Through 2023
Table 38 : UK Market for CRISPR Technology, Through 2023
Table 39 : UK Market for CRISPR Technology, by End User, Through 2023
Table 40 : UK Market for CRISPR Technology, by Application, Through 2023
Table 41 : Asia-Pacific Market for CRISPR Technology, Through 2023
Table 42 : Asia-Pacific Market for CRISPR Technology, by End User, Through 2023
Table 43 : Asia-Pacific Market for CRISPR Technology, by Application, Through 2023
Table 44 : Chinese Market for CRISPR Technology, Through 2023
Table 45 : Chinese Market for CRISPR Technology, by End User, Through 2023
Table 46 : Chinese Market for CRISPR Technology, by Application, Through 2023
Table 47 : Indian Market for CRISPR Technology, Through 2023
Table 48 : Indian Market for CRISPR Technology, by End User, Through 2023
Table 49 : Indian Market for CRISPR Technology, by Application, Through 2023
Table 50 : Rest of the World Market for CRISPR Technology, Through 2023
Table 51 : Rest of the World Market for CRISPR Technology, by End User, Through 2023
Table 52 : Rest of the World Market for CRISPR Technology, by Application, Through 2023
Table 53 : Caribou Biosciences: Product Portfolio
Table 54 : Caribou Biosciences: Recent Developments
Table 55 : CRISPR Therapeutics: Product Portfolio
Table 56 : CRISPR Therapeutics: Recent Developments
Table 57 : Editas Medicine: Product Portfolio
Table 58 : Editas Medicine: Recent Developments
Table 59 : Genscript: Product Portfolio
Table 60 : Genscript: Recent Developments
Table 61 : Horizon Discovery: Product Portfolio
Table 62 : Horizon Discovery: Recent Developments
Table 63 : Integrated DNA Technologies (IDT): Product Portfolio
Table 64 : Integrated DNA Technologies (IDT): Recent Developments
Table 65 : Intellia Therapeutics Inc.: Product Portfolio
Table 66 : Intellia Therapeutics Inc.: Recent Developments
Table 67 : Lonza Group Ltd.: Product Portfolio
Table 68 : Lonza Group Ltd.: Recent Developments
Table 69 : New England Biolabs Inc.: Product Portfolio
Table 70 : New England Biolabs Inc.: Recent Developments
Table 71 : OriGene Technologies: Product Portfolio
Table 72 : Precision BioSciences: Product Portfolio
Table 73 : Precision BioSciences: Recent Developments
Table 74 : Sangamo Therapeutics Inc.: Product Portfolio
Table 75 : Sangamo Therapeutics Inc.: Recent Developments
Table 76 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 77 : Thermo Fisher Scientific Inc.: Recent Developments
Table 78 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Product Portfolio
Table 79 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Recent Developments